STOCKHOLDERS’ EQUITY (Tables)

9 Months Ended

Mar. 31, 2022

Equity [Abstract]

Summary of weighted-average assumptions used to estimate the fair values of the stock options granted

	Enochian Biosciences Inc.
Expected term (in years)		5.0 – 6.5
Volatility		82.29%-90.21%
Risk free interest rate		0.77%-1.87%
Dividend yield		0%

Summary of stock option activity

Options Outstanding										Options Exercisable
	Exercise Price Ranges		Number Outstanding		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price			Number Exercisable		Weighted Average Remaining Contractual Life (years)		Weighted Average Exercise Price
	$	2.00–4.50		279,143		8.44		$	3.23		255,637		8.40	$	3.24
	$	4.51–6.50		3,545,722		8.97		$	4.80		471,998		6.85	$	6.17
	$	6.51–8.00		876,242		8.59		$	7.98		556,094		7.96	$	7.93
Total				4,701,108		8.86		$	5.30		1,283,729		7.64	$	6.35

Summary of stock option activity

	Shares			Weighted Average Exercise Price		Average Remaining Life		Weighted Average Intrinsic Value
Outstanding at beginning of period		1,329,153		$	6.24		8.42	$	511,239
Granted		3,400,355		$	4.93		—	$	—
Exercised		—		$	—		—	$	—
Forfeited		—		$	—		—	$	—
Expired		(28,400	)	$	2.15		—	$	—
Outstanding at end of period		4,701,108		$	5.30		8.86	$	9,808,104
Exercisable at end of period		1,283,729		$	6.35		7.64	$	1,153,019

Summary of common stock purchase warrants outstanding

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Life
Outstanding at beginning of period		1,350,000		$	1.30		1.02
Granted		—		$	—		—
Exercised		(100,000	)	$	1.30		—
Cancelled/Expired		—		$	—		—
Outstanding and exercisable at end of period		1,250,000		$	1.30		.28

Summary of common stock purchase warrants

				Underlying Warrants Outstanding			Equivalent Shares Exercisable
Exercise Prices		Equivalent Shares		Weighted Average Remaining Contractual Life (years)	Weighted Average Exercise Price		Number Exercisable		Weighted Average Exercise Price
$	1.30		1,250,000	.28	$	1.30		1,250,000	$	1.30

Summary of restricted stock units outstanding

	Shares			Weighted Average Issuance Price		Weighted Average Remaining Life		Weighted Average Intrinsic Value
Outstanding at beginning of period		5,000		$	6.15	$	.02	$	—
Granted		36,266			—		—		—
Exercised		(41,266	)		—		—		—
Cancelled/Expired		—			—		—		—
Outstanding at end of period		—		$	—	$	—	$	—